(2-Phenyl-imidazo[1,2-a]pyridin-3-yl)-acetic acid, 96%, 1g

Capillary pipettes with sodium heparination, 60 µl, 1000 pieces

Trichloroacetic acid, 500 g

4-Chloro-2,1,3-benzoxadiazole>98.0%(T)5g

4-(TERT-BUTYLDIMETHYLSILYLOXY)-2,6-DIFLUOROPHENYLBORONIC ACID, 97.0%, 1g

(S)-9,10-Difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, 95.0%, 5g

3-Chloro-2-fluorobenzyl Bromide>96.0%(GC)(T)1g

Methyl 3-bromoimidazo[1,5-a]pyridine-1-carboxylate, 95.0%, 250mg

N,N,N'-Triphenylbenzidine>97.0%(GC)1g

3,4-Diamino-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)benzene-1-sulfonamide, 98%, 100mg

tert-Butyl ((2-chloropyrimidin-5-yl)methyl)carbamate, 98%, 500mg

6-Bromo-1H-indazol-3-amine, 98.0%, 1g

Warning symbol Individual label tested in practice, Substances harmful or irritating to health, Side length 200 mm, 1 piece